Enhancing nitric oxide bioavailability via exogen nitric oxide synthase and l-arginine attenuates ischemia-reperfusion-induced microcirculatory alterations

Background Nitric oxide (NO) is an important cytoprotective agent against ischemia and reperfusion injury (IRI). Enhancing NO bioavailability via exogen NO synthases (NOSs) and L-arginine promotes conversation to NO, circumventing the problem of nonfunctioning NOSs under hypoxic and acidic condition...

Full description

Saved in:
Bibliographic Details
Main Authors: Engel, Holger (Author) , Friedrich, Stefanie (Author) , Schleich, Christoph (Author) , Gebhard, Martha-Maria (Author) , Gross, Wolfgang (Author) , Germann, Günter (Author) , Reichenberger, Matthias (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: Annals of plastic surgery
Year: 2017, Volume: 79, Issue: 4, Pages: e25-e29
ISSN:1536-3708
DOI:10.1097/SAP.0000000000000148
Online Access:Verlag, Volltext: http://dx.doi.org/10.1097/SAP.0000000000000148
Verlag, Volltext: https://journals.lww.com/annalsplasticsurgery/Abstract/2017/10000/Enhancing_Nitric_Oxide_Bioavailability_via_Exogen.17.aspx
Get full text
Author Notes:Holger Engel, MD, Stefanie Friedrich, MD, Christoph Schleich, MD, Martha-Maria Gebhardt, MD, PhD, Wolfgang Gross, PhD, Günter Germann, MD, PhD, and Matthias Reichenberger, MD, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1574136569
003 DE-627
005 20230427042852.0
007 cr uuu---uuuuu
008 180507s2017 xx |||||o 00| ||eng c
024 7 |a 10.1097/SAP.0000000000000148  |2 doi 
035 |a (DE-627)1574136569 
035 |a (DE-576)504136569 
035 |a (DE-599)BSZ504136569 
035 |a (OCoLC)1341008335 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Engel, Holger  |d 1976-  |e VerfasserIn  |0 (DE-588)132925214  |0 (DE-627)528681265  |0 (DE-576)265625378  |4 aut 
245 1 0 |a Enhancing nitric oxide bioavailability via exogen nitric oxide synthase and l-arginine attenuates ischemia-reperfusion-induced microcirculatory alterations  |c Holger Engel, MD, Stefanie Friedrich, MD, Christoph Schleich, MD, Martha-Maria Gebhardt, MD, PhD, Wolfgang Gross, PhD, Günter Germann, MD, PhD, and Matthias Reichenberger, MD, PhD 
264 1 |c 2017 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published December 29, 2013 
500 |a Druckfehler bei Verfasserin Martha-Maria Gebhard 
500 |a Gesehen am 07.05.2018 
520 |a Background Nitric oxide (NO) is an important cytoprotective agent against ischemia and reperfusion injury (IRI). Enhancing NO bioavailability via exogen NO synthases (NOSs) and L-arginine promotes conversation to NO, circumventing the problem of nonfunctioning NOSs under hypoxic and acidic conditions. In this study, the authors evaluated the therapeutic efficacy of endothelial, inducible and neuronal NOS, and L-arginine on reperfusion-induced microcirculatory alterations and hemodynamic adverse effects in the microvasculature of skeletal muscle. Methods Vascular pedicle isolated rat cremaster model was used that underwent 2 hours of warm ischemia followed by 1 hour of reperfusion. At 30 minutes before ischemia, normal saline (control group with/without ischemia), endothelial-, inducible-, and neuronal NOSs (2 IE) and L-arginine (50 mg/kg BW) were administered systemically (IV). Ischemia-reperfusion-induced microcirculatory alterations were measured after 1 hour of reperfusion. Mean arterial blood pressure and heart frequency were measured throughout the experiment to determine hemodynamic adverse effects. Results The isoforms of NOSs and L-arginine attenuated ischemia-reperfusion-induced vasoconstriction, improved red blood cell velocity, capillary flow, and leukocyte adherence to the endothelium wall. Hemodynamics was stable throughout the experiment.Conclusions Enhancing NO bioavailability via exogen application of NOSs and L-arginine significantly attenuated ischemia-reperfusion-induced microcirculatory alterations in the microvasculature of skeletal muscle. Significant hemodynamic adverse effects were not present, thus demonstrating this approach might be useful for therapeutic intervention. This “pharmacologic preconditioning” could be an easy and effective interventional strategy to uphold conversation of L-arginine to NO under ischemic conditions. 
700 1 |a Friedrich, Stefanie  |d 1976-  |e VerfasserIn  |0 (DE-588)128783389  |0 (DE-627)379683539  |0 (DE-576)297330896  |4 aut 
700 1 |a Schleich, Christoph  |d 1983-  |e VerfasserIn  |0 (DE-588)1047660652  |0 (DE-627)778751163  |0 (DE-576)401467953  |4 aut 
700 1 |a Gebhard, Martha-Maria  |d 1948-  |e VerfasserIn  |0 (DE-588)1076763278  |0 (DE-627)835312879  |0 (DE-576)445612789  |4 aut 
700 1 |a Gross, Wolfgang  |d 1954-  |e VerfasserIn  |0 (DE-588)1074045599  |0 (DE-627)83021576X  |0 (DE-576)435557963  |4 aut 
700 1 |a Germann, Günter  |d 1952-  |e VerfasserIn  |0 (DE-588)1145880673  |0 (DE-627)1006989218  |0 (DE-576)17218732X  |4 aut 
700 1 |a Reichenberger, Matthias  |e VerfasserIn  |0 (DE-588)1070543772  |0 (DE-627)824002520  |0 (DE-576)430210531  |4 aut 
773 0 8 |i Enthalten in  |t Annals of plastic surgery  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1978  |g 79(2017), 4, Seite e25-e29  |h Online-Ressource  |w (DE-627)337806918  |w (DE-600)2063013-X  |w (DE-576)101050372  |x 1536-3708  |7 nnas  |a Enhancing nitric oxide bioavailability via exogen nitric oxide synthase and l-arginine attenuates ischemia-reperfusion-induced microcirculatory alterations 
773 1 8 |g volume:79  |g year:2017  |g number:4  |g pages:e25-e29  |g extent:5  |a Enhancing nitric oxide bioavailability via exogen nitric oxide synthase and l-arginine attenuates ischemia-reperfusion-induced microcirculatory alterations 
856 4 0 |u http://dx.doi.org/10.1097/SAP.0000000000000148  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://journals.lww.com/annalsplasticsurgery/Abstract/2017/10000/Enhancing_Nitric_Oxide_Bioavailability_via_Exogen.17.aspx  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180508 
993 |a Article 
994 |a 2017 
998 |g 1070543772  |a Reichenberger, Matthias  |m 1070543772:Reichenberger, Matthias  |d 60000  |d 61800  |e 60000PR1070543772  |e 61800PR1070543772  |k 0/60000/  |k 1/60000/61800/  |p 7  |y j 
998 |g 1145880673  |a Germann, Günter  |m 1145880673:Germann, Günter  |d 60000  |d 61800  |e 60000PG1145880673  |e 61800PG1145880673  |k 0/60000/  |k 1/60000/61800/  |p 6 
998 |g 1074045599  |a Gross, Wolfgang  |m 1074045599:Gross, Wolfgang  |d 60000  |d 61800  |e 60000PG1074045599  |e 61800PG1074045599  |k 0/60000/  |k 1/60000/61800/  |p 5 
998 |g 1076763278  |a Gebhard, Martha-Maria  |m 1076763278:Gebhard, Martha-Maria  |d 50000  |e 50000PG1076763278  |k 0/50000/  |p 4 
998 |g 1047660652  |a Schleich, Christoph  |m 1047660652:Schleich, Christoph  |d 60000  |d 61800  |e 60000PS1047660652  |e 61800PS1047660652  |k 0/60000/  |k 1/60000/61800/  |p 3 
998 |g 128783389  |a Friedrich, Stefanie  |m 128783389:Friedrich, Stefanie  |d 60000  |d 61800  |e 60000PF128783389  |e 61800PF128783389  |k 0/60000/  |k 1/60000/61800/  |p 2 
998 |g 132925214  |a Engel, Holger  |m 132925214:Engel, Holger  |d 50000  |e 50000PE132925214  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1574136569  |e 3008481841 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Holger Engel, MD, Stefanie Friedrich, MD, Christoph Schleich, MD, Martha-Maria Gebhardt, MD, PhD, Wolfgang Gross, PhD, Günter Germann, MD, PhD, and Matthias Reichenberger, MD, PhD"]},"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"id":{"eki":["1574136569"],"doi":["10.1097/SAP.0000000000000148"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1978","dateIssuedDisp":"1978-"}],"id":{"issn":["1536-3708"],"eki":["337806918"],"zdb":["2063013-X"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Enhancing nitric oxide bioavailability via exogen nitric oxide synthase and l-arginine attenuates ischemia-reperfusion-induced microcirculatory alterationsAnnals of plastic surgery","note":["Gesehen am 27.01.03"],"language":["eng"],"recId":"337806918","pubHistory":["1.1978 -"],"part":{"extent":"5","volume":"79","text":"79(2017), 4, Seite e25-e29","pages":"e25-e29","issue":"4","year":"2017"},"titleAlt":[{"title":"Plastic surgery"}],"title":[{"title":"Annals of plastic surgery","title_sort":"Annals of plastic surgery"}]}],"person":[{"family":"Engel","given":"Holger","display":"Engel, Holger","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Friedrich, Stefanie","given":"Stefanie","family":"Friedrich"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Schleich, Christoph","given":"Christoph","family":"Schleich"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Gebhard, Martha-Maria","given":"Martha-Maria","family":"Gebhard"},{"family":"Gross","given":"Wolfgang","display":"Gross, Wolfgang","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Germann, Günter","roleDisplay":"VerfasserIn","given":"Günter","family":"Germann"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Reichenberger, Matthias","given":"Matthias","family":"Reichenberger"}],"title":[{"title_sort":"Enhancing nitric oxide bioavailability via exogen nitric oxide synthase and l-arginine attenuates ischemia-reperfusion-induced microcirculatory alterations","title":"Enhancing nitric oxide bioavailability via exogen nitric oxide synthase and l-arginine attenuates ischemia-reperfusion-induced microcirculatory alterations"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["First published December 29, 2013","Druckfehler bei Verfasserin Martha-Maria Gebhard","Gesehen am 07.05.2018"],"recId":"1574136569","language":["eng"]} 
SRT |a ENGELHOLGEENHANCINGN2017